My Portfolio
+
LINK YOUR PORTFOLIO

LENSAR Inc LNSR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:39 PM EDT
5.74UNCH (UNCH)
Volume
569
Close
5.74UNCH (UNCH)
Volume
52,074
52 week range
5.06 - 13.67
Loading...
  • Open5.66
  • Day High5.90
  • Day Low5.64
  • Prev Close5.74
  • 52 Week High13.67
  • 52 Week High Date06/05/25
  • 52 Week Low5.06
  • 52 Week Low Date04/27/26

Latest On LENSAR Inc

 

Key Stats

  • Market Cap69.479M
  • Shares Out12.10M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta0.87

Latest On LENSAR Inc

 

KEY STATS

  • Open5.66
  • Day High5.90
  • Day Low5.64
  • Prev Close5.74
  • 52 Week High13.67
  • 52 Week High Date06/05/25
  • 52 Week Low5.06
  • 52 Week Low Date04/27/26
  • Market Cap69.479M
  • Shares Out12.10M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta0.87

RATIOS/PROFITABILITY

  • EPS (TTM)-0.58
  • P/E (TTM)-9.95
  • Fwd P/E (NTM)-11.96
  • EBITDA (TTM)926,000.00
  • ROE (TTM)-16,631.70%
  • Revenue (TTM)57.704M
  • Gross Margin (TTM)45.71%
  • Net Margin (TTM)50.94%
  • Debt To Equity (MRQ)20.35%

EVENTS

  • Earnings Date08/05/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. The Company's product portfolio includes the LENSAR Laser System and the ALLY Robotic Cataract Laser System and their associated consumable components. It has developed its ALLY System as a compact, highly ergonomic system utilizing an extremely fast...
William Link Ph.D.
Independent Chairman of the Board
Nicholas Curtis
Chief Executive Officer, Director
Alan Connaughton
Chief Operating Officer
Michael Rossi
Interim Chief Financial Officer and Principal Financial Officer
Address
2800 Discovery Drive, Suite 100
Orlando, FL
32826
United States